Decreased levels of Fibroblast Growth Factor 21 are correlated with improved hypoglycemia in patients with insulinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Decreased levels of Fibroblast Growth Factor 21 are correlated with improved hypoglycemia in patients with insulinoma

Published:2017-02-22 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Li Xu,Yu Haoyong,Yin Jun,Li Lianxi,Zhou Jian,Li Ming,Li Qing,Chen Haibing,Liu Fang,Bao Yuqian,Han Junfeng,Jia Weiping

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep43123.pdf

Reference31 articles.

1. Kharitonenkov, A. et al. FGF-21 as a novel metabolic regulator. J Clin Invest. 115, 1627–1635, doi: 10.1172/JCI23606 (2005).

2. Coskun, T. et al. Fibroblast growth factor 21 corrects obesity in mice. Endocrinology. 149, 6018–6027, doi: 10.1210/en.2008-0816 (2008).

3. Xu, J. et al. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice. Diabetes. 58, 250–259, doi: 10.2337/db08-0392 (2009).

4. Kharitonenkov, A. et al. The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21. Endocrinology. 148, 774–781, doi: 10.1210/en.2006-1168 (2007).

5. Gaich, G. et al. The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes. Cell Metab. 18, 333–340, doi: 10.1016/j.cmet.2013.08.005 (2013).

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PACAP and PAC1 Receptor Expression in Human Insulinomas;International Journal of Peptide Research and Therapeutics;2021-04-09

2. Fibroblast growth factor 21 in lipid metabolism and non-alcoholic fatty liver disease;Clinica Chimica Acta;2019-11

3. A review of fibroblast growth factor 21 in diabetic cardiomyopathy;Heart Failure Reviews;2019-06-07

4. Involvement of growth factors in diabetes mellitus and its complications: A general review;Biomedicine & Pharmacotherapy;2018-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3